Demographic Data |
Relation to Proband |
proband |
Age at Sampling |
17 YR |
Sex |
Male |
Age of Onset(If not a control) |
2 YR |
Age at Diagnosis(If not a control) |
17 YR |
Racial Category |
White |
Country |
UNITED KINGDOM |
|
Data Elements |
Clinical Element Type: General NIGMS Catalog Remarks |
(Baseline) |
Mutation Information |
Gene, variant, consequence, and exon number: |
MUTATION IN SLC6A8 GENE: C.373A>T AT POSITION 153,690,485, NM_005629.3(P.ASN125TYR, NP_005620.1) |
Zygosity: |
Heterozygous |
Other variants: |
OTHER VARIANTS: HCFC1 C.2590G>A AT POSITION 153,956,670, NM005334.2 (P.ALA864THR, NP_005325.2), AND MTCO3 C.263C>T AT POSITION 9,469, ENST00000362079 (P.THR88ILE, ENSP_00000354982.2) |
Age of Symptom Onset and Age at Diagnosis |
Age of Symptom Onset: |
2 YEARS |
Age at Diagnosis: |
17 YEARS; DIAGNOSED BY GENETICIST |
In Utero History Information |
|
|
Birth History Information |
|
|
Dysmorphic Features |
|
|
Neurological Symptoms |
|
|
Additional Information: |
RESTING TREMORS, EPILEPSY |
Optical and Audiological Symptoms |
|
|
Musculoskeletal Symptoms |
|
|
Developmental Milestones |
|
|
Gastrointestinal Symptoms |
|
|
Genitourinary Symptoms |
|
|
Respiratory and Cardiovascular Symptoms |
|
|
Cognitive and Behavioral Symptoms |
|
Attention deficit hyperactivity disorder
|
Additional Information: |
SLD, MENTALLY 2 YEARS OLD AT 17 YEARS OF AGE |
Additional Information |
Testing Performed |
Cognitive and Behavioral Testing: |
BRAIN MRI CONFIRMED CEREBRAL CREATINE DEFICIENCY |
Metabolic, Hematologic, and Endocrinologic Testing: |
URINE TEST SHOWED GREATLY INCREASED URINARY CREATINE CONSISTENT WITH DIAGNOSIS; URINE GAA IS AT THE TOP OF NORMAL RANGE; PLASMA GAA IS WITHIN NORMAL RANGE |
Treatments and Assistive Devices |
|
Occupational therapy Physical therapy Speech therapy
|
Additional Testing: |
PSYCHOLOGICAL THERAPY |
Medications |
|
RISPERIDONE |
Family History |
Remarks |
See Phenotypic Data tab. |